| Followers | 1806 |
| Posts | 33595 |
| Boards Moderated | 2 |
| Alias Born | 04/04/2017 |
Monday, November 04, 2024 9:23:03 AM
CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy
Newsfile Corp.
Newsfile Corp
Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the appointment of Mr. Charles Tamburello as a new member of the board of directors. His extensive experience in the public markets, which spans nearly three decades, will play a crucial role in driving the company's mergers and acquisitions (M&A) strategy forward.
Mr. Tamburello has been instrumental in the success of hundreds of public and private companies since 1995, leveraging his deep industry knowledge and valuable connections to facilitate growth and expansion. His track record of orchestrating successful M&A transactions aligns perfectly with CBIH's strategic goals as we look to enhance our capabilities and reach. He is the owner operator of Global Discovery Group, a dynamic platform designed to facilitate engagement between public companies and the investment community, which offers a highly effective and time-efficient way for companies to showcase their latest developments, new products, services, and significant announcements.
"Recognizing the challenges ahead as we strive to reach our ambitious benchmarks, we are committed to bringing on top-tier talent and strategic guidance. Mr. Tamburello exemplifies this commitment," said John Jones, CBIH Treasurer and Director. "His extensive experience in capital acquisition and expertise in navigating complex industries will provide our shareholders with confidence that we are positioned for sustainable growth and value creation."
Charles Tamburello expressed his enthusiasm about joining CBIH, stating, "I'm excited to be a part of the vision of Cannabis Bioscience International and the journey of helping everyday people throughout the world, conquer debilitating ailments and improve their lives."
Mr. Tamburello's appointment to the CBIH board significantly strengthens the company's potential for successful mergers and acquisitions (M&A). His extensive background in executing M&A transactions across diverse sectors equips CBIH with the strategic insights and negotiation skills necessary to identify high-value acquisition targets and maximize deal success. Tamburello's deep industry connections and leadership of The Emerging Growth Conference provide CBIH with enhanced access to potential partners and acquisition opportunities, increasing the likelihood of securing advantageous deals that align with CBIH's growth objectives.
Furthermore, his expertise in capital raising allows CBIH to pursue acquisitions more aggressively, ensuring the company has the necessary resources to act swiftly on opportunities and expand its portfolio. This combination of M&A experience, industry influence, and capital acquisition skills provides CBIH with a competitive edge, enabling the company to grow strategically through targeted acquisitions that bolster its market position and drive long-term shareholder value.
This powerful combination of skills and connections positions CBIH to seize high-value opportunities and strategically expand our portfolio, strengthening our market position and delivering sustained value for shareholders. With Mr. Tamburello's leadership, we are more confident than ever in our path to becoming an industry leader and achieving long-term, transformative growth.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
https://images.newsfilecorp.com/files/10188/228741_2ab2feab447cd92f_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228741
SOURCE Cannabis Bioscience International Holdings
https://api.newsfilecorp.com/newsinfo/228741/130
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=3034183
Newsfile Corp.
Newsfile Corp
Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the appointment of Mr. Charles Tamburello as a new member of the board of directors. His extensive experience in the public markets, which spans nearly three decades, will play a crucial role in driving the company's mergers and acquisitions (M&A) strategy forward.
Mr. Tamburello has been instrumental in the success of hundreds of public and private companies since 1995, leveraging his deep industry knowledge and valuable connections to facilitate growth and expansion. His track record of orchestrating successful M&A transactions aligns perfectly with CBIH's strategic goals as we look to enhance our capabilities and reach. He is the owner operator of Global Discovery Group, a dynamic platform designed to facilitate engagement between public companies and the investment community, which offers a highly effective and time-efficient way for companies to showcase their latest developments, new products, services, and significant announcements.
"Recognizing the challenges ahead as we strive to reach our ambitious benchmarks, we are committed to bringing on top-tier talent and strategic guidance. Mr. Tamburello exemplifies this commitment," said John Jones, CBIH Treasurer and Director. "His extensive experience in capital acquisition and expertise in navigating complex industries will provide our shareholders with confidence that we are positioned for sustainable growth and value creation."
Charles Tamburello expressed his enthusiasm about joining CBIH, stating, "I'm excited to be a part of the vision of Cannabis Bioscience International and the journey of helping everyday people throughout the world, conquer debilitating ailments and improve their lives."
Mr. Tamburello's appointment to the CBIH board significantly strengthens the company's potential for successful mergers and acquisitions (M&A). His extensive background in executing M&A transactions across diverse sectors equips CBIH with the strategic insights and negotiation skills necessary to identify high-value acquisition targets and maximize deal success. Tamburello's deep industry connections and leadership of The Emerging Growth Conference provide CBIH with enhanced access to potential partners and acquisition opportunities, increasing the likelihood of securing advantageous deals that align with CBIH's growth objectives.
Furthermore, his expertise in capital raising allows CBIH to pursue acquisitions more aggressively, ensuring the company has the necessary resources to act swiftly on opportunities and expand its portfolio. This combination of M&A experience, industry influence, and capital acquisition skills provides CBIH with a competitive edge, enabling the company to grow strategically through targeted acquisitions that bolster its market position and drive long-term shareholder value.
This powerful combination of skills and connections positions CBIH to seize high-value opportunities and strategically expand our portfolio, strengthening our market position and delivering sustained value for shareholders. With Mr. Tamburello's leadership, we are more confident than ever in our path to becoming an industry leader and achieving long-term, transformative growth.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. The words "believe," "expect," "should," "intend," "estimate," "projects," variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. These forward-looking statements are based upon the Company's current expectations and are subject to a number of risks, uncertainties, and assumptions. The Company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. Among the important factors that could cause actual results to differ significantly from those expressed or implied by such forward-looking statements are risks that are detailed in the Company's filings, which are on file at www.OTCmarkets.com.
For more information contact us at:
(214) 733-0868
ir@cbih.net
Dante Picazo
CEO - CBIH
Website: www.cbih.net
X: www.twitter.com/cbihstock
Instagram: www.instagram.com/CBIHSTOCK
https://images.newsfilecorp.com/files/10188/228741_2ab2feab447cd92f_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228741
SOURCE Cannabis Bioscience International Holdings
https://api.newsfilecorp.com/newsinfo/228741/130
https://www.otcmarkets.com/stock/CBIH/news/story?e&id=3034183
Bullish
Recent CBIH News
- Form 253G2 - • Edgar (US Regulatory) • 05/21/2026 06:43:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 01:45:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/16/2026 07:39:12 PM
- Form 253G2 - • Edgar (US Regulatory) • 04/15/2026 04:45:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 04/14/2026 06:31:40 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 04/14/2026 04:15:03 AM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 03/27/2026 09:25:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/19/2026 09:11:13 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 01/14/2026 06:05:31 PM
- CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence • Newsfile • 01/12/2026 12:00:00 PM
- CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition • Newsfile • 01/05/2026 12:00:00 PM
- CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways • Newsfile • 12/29/2025 12:00:00 PM
- CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities • Newsfile • 12/22/2025 12:00:00 PM
- Potential Rescheduling to Schedule III Could Reward Decades of Scientific Preparation and Regulatory Discipline • Newsfile • 12/15/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/22/2025 08:20:36 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 10/15/2025 08:00:25 PM
- CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery • Newsfile • 10/13/2025 11:00:00 AM
- CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center • Newsfile • 09/29/2025 11:00:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/22/2025 08:15:20 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/02/2025 08:12:37 PM
